ThursdayDec 30, 2021 9:30 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Named Exclusive Water Partner for Canada’s Country Music Week 2021; BevCanna Named One of 101 Top Food and Beverage Startups and Companies in Canada

BevCanna Enterprises announced that its in-house brand, TRACE was designated as the exclusive water partner for the Country Music Week 2021 The TRACE brand features a range of products sourced from springs located deep within the Rocky Mountains; the product range includes Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water and Natural Flavor Sparkling Spring Water among others BevCanna Enterprises separately announced that it has been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and…

Continue Reading

TuesdayDec 28, 2021 9:30 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Reports Strong Third Quarter 2021 Financial Results; Sees Revenues Soar by Upwards of 1,000% YoY

BevCanna Enterprises recently published its unaudited financial results for the third quarter of 2021 The company recorded over 1,000% revenue growth year-over-year which separately recording positive gross profit for the quarter In addition to receiving its initial orders from the British Columbia, Alberta and Ontario Cannabis Distribution companies, BevCanna has also signed an agreement with UNFI Canada – thus leading to a significant expansion in its geographical distribution footprint across Canada BevCanna also announced the acquisition of Embark Health Inc, a leader in solventless cannabis extraction, as it actively diversifies from its core beverage manufacturing business BevCanna Enterprises (CSE: BEV)…

Continue Reading

MondayDec 27, 2021 1:33 pm

Flora Growth Corp. (NASDAQ: FLGC) Marks 2021 Close with Product Diversification and Market Expansion

Flora Growth recently expanded into Mexico and Spain with its Mind Naturals and Awe CBD skincare brands Additionally, the company ventured into the dry herb market through Vessel brand, its wholly owned subsidiary The recent licensing agreement with Tonino Lamborghini marks Flora Growth’s aggressive product diversification plan that has defined its 2021 calendar year All the decisions and moves made by the company so far have been geared toward growing the company’s market share, expanding its market reach, and increasing value for its shareholders Flora Growth (NASDAQ: FLGC) completed its first traditional cannabis Initial Public Offering (“IPO”) in May 2021.…

Continue Reading

MondayDec 27, 2021 1:14 pm

Marijuana Company of America Inc. (MCOA) Completes VBF Brands Acquisition, Highlighting Growth Strategy

Marijuana Company of America, Inc. has been expanding its portfolio in recent months through acquisitions and partnerships designed to enhance the company’s revenue stream MCOA’s trademarked hempsmart brand of CBD products has been joined by verticals including marijuana cultivator and distributor VBF Brands, CBD brands distributor cDistro, in-store advertiser VapeTV US, and other industry solutions The recent completion of VBF Brands’ acquisition grants MCOA efficiency and sustainable cultivation techniques in its product development Efforts to expand the legalization of recreational and medicinal marijuana at the federal level have been gaining steam again, portending significant opportunities for growth in 2022 As…

Continue Reading

MondayDec 27, 2021 1:08 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expects Study Results to Show its Patented Tech’s Value in Treating Hypertension Patients

Lexaria Bioscience is preparing to file an Investigational New Drug application with the U.S. Food and Drug Administration for its patented technology’s use in treating hypertension (high blood pressure) The company has completed multiple studies of the benefits of DehydraTECH(TM), in combination with cannabidiol to combat hypertension conditions and consequentially benefit cardiovascular patients Lexaria recently announced that it is nearing completion of a third human study in which the company expects to further explore whether DehydraTECH-CBD successfully treats high pulmonary blood pressure A comprehensive six-week human clinical study is expected to begin soon Lexaria Bioscience (NASDAQ: LEXX) is nearing completion…

Continue Reading

MondayDec 27, 2021 12:00 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces White-Label Manufacturing Agreement With Averi Health Products

BevCanna Enterprises is a diversified health & wellness beverage company which specializes in providing white-label production and distribution solutions to its various partners The company recently entered into a manufacturing and distribution agreement with Averi Health Products, which will see BevCanna market Averi’s diverse range of non-alcoholic, cannabis-infused cocktails BevCanna has recently announced tie-ups with Keef Brands as well as with The Tinley Beverage Company to produce and distribute its products within the Canadian territory BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline,…

Continue Reading

WednesdayDec 22, 2021 12:06 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Major Discovery; Increasing the Effectiveness of Orally Administered CBD

In a recent human clinical trial, HYPER-H21-2, DehydraTECH™-CBD reduced arterial stiffness, potentially broadening Lexaria's application's ability to treat cardiovascular and other diseases beyond hypertension Lexaria’s patented technology DehydraTECH improves how APIs enter the bloodstream –making multiple benefits possible such as increased delivery speed, increase in brain absorbency, higher bioavailability, and lower costs The company has patent protection received for delivery of nicotine, vitamins, NSAIDs, terpenes and cannabinoids; and patents pending for delivery of estrogen, testosterone, PDE5 inhibitors, antiviral drugs and more Oral absorption is the most convenient and widely used administration route for taking medications. Decades of research have advanced…

Continue Reading

TuesdayDec 21, 2021 12:06 pm

As Cannabis Market Continues to Expand, Marijuana Company of America Inc. (MCOA) Anticipates Sustained Growth Following Record-Breaking Quarter

Education and job opportunities are being created for the sector, as more states and more countries around the word are pushing for cannabis legalization MCOA offers diverse operations that include both wholly-owned subsidiaries and investment interests, including Cannabis Global Inc., Eco Innovation Group Inc., and Natural Plant Extract During Q3 2021, the company saw its highest revenue earning quarter since it became public  Despite challenges posed by the global pandemic, the legalized cannabis market is expected to grow significantly in the next five years. The market was valued at approximately $19.96 billion in 2018, and it is expected to grow…

Continue Reading

TuesdayDec 21, 2021 10:37 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Natural Alkaline Spring Water Named as the Official Water Supplier for Vancouver’s 2022 Canadian E-Prix Event

BevCanna Enterprises’ TRACE line of natural alkaline and mineral-infused spring waters have been named as the official water supplier for Vancouver’s 2022 Canadian E-Prix event TRACE Natural Alkaline Spring Water, which originates from BevCanna’s wholly owned natural spring water aquifer in British Columbia, are renowned for their optimal mineral content and eco-friendly packaging  BevCanna will launch a unique, commemorative package for its signature water brand in the run-up to the Vancouver E-Prix The event will serve to further propagate the TRACE brand name, with the company already named as the official water supplier to British Columbia’s firefighters BevCanna Enterprises (CSE:…

Continue Reading

FridayDec 17, 2021 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Reduces Arterial Stiffness in Study HYPER-H21-2 Broadening Applications Beyond Hypertension

Cardiovascular diseases are the leading cause of death worldwide and arterial stiffness serves as a significant marker of related conditions, including hypertension (high blood pressure) The company’s studies earlier this year indicated the potential of DehydraTECH to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation Arterial stiffness is a noted indicator of diseases such as heart, kidney and pancreas organ ailments that increase mortality with age, therefore the ability to reduce arterial stiffness may have implications for improving human wellness and longevity HYPER-H21-2 results evidence…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722